We previously reported that the percentage of CD4+ T cells producing IL-17 and IL-22 (Th17 cells) is significantly greater in patients with active EGPA than in healthy controls or in patients with asthma, chronic eosinophilic pneumonia, or inactive EGPA [40]. This evidence concerns the gene IL17A and chronic eosinophilic pneumonia.